• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在切除的早期非小细胞肺癌中,PD-L1 淋巴细胞与 CD4、Foxp3CD4、IL17CD4 T 细胞和巨噬细胞亚型相关联。

PD-L1 Lymphocytes Are Associated with CD4, Foxp3CD4, IL17CD4 T Cells and Subtypes of Macrophages in Resected Early-Stage Non-Small Cell Lung Cancer.

机构信息

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.

Department of Pathology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.

出版信息

Int J Mol Sci. 2024 Oct 9;25(19):10827. doi: 10.3390/ijms251910827.

DOI:10.3390/ijms251910827
PMID:39409156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11477418/
Abstract

The non-canonical PD-L1 pathway revealed that programmed-death ligand 1 (PD-L1) expression in immune cells also plays a crucial role in immune response. Moreover, immune cell distribution in a tumour microenvironment (TME) is pivotal for tumour genesis. However, the results remain controversial and further research is needed. Distribution of PD-L1-positive (PD-L1) tumour-infiltrating lymphocytes in the context of TME was assessed in 72 archival I-III stage surgically resected NSCLC tumour specimens. Predominant PD-L1 lymphocyte distribution in the tumour stroma, compared to islets, was found ( = 0.01). Higher PD-L1 lymphocyte infiltration was detected in smokers due to their predominance in the stroma. High PD-L1 lymphocyte infiltration in tumour stroma was more common in tumours with higher CD4 T cell infiltration in islets and stroma, Foxp3CD4 T cell infiltration in islets and lover M1 macrophage infiltration in the stroma ( = 0.034, = 0.034, = 0.005 and = 0.034 respectively). Meanwhile, high PD-L1 lymphocyte infiltration in islets was predominantly found in tumours with high levels of IL-17ACD4 T cells in islets and Foxp3CD4 T cells in islets and stroma ( = 0.032, = 0.009 and = 0.034, respectively). Significant correlations between PD-L1 lymphocytes and tumour-infiltrating CD4, Foxp3CD4, IL-17ACD4 T cells and M2 macrophages were found. An analysis of the tumour-immune phenotype revealed a significant association between PD-L1 expression and IL17CD4 and Foxp3CD4 immune phenotypes. PD-L1 lymphocytes are associated with the distribution of CD4, Foxp3CD4, IL17ACD4 T cells, M1 and M2 macrophages in TME of resected NSCLC.

摘要

非典型 PD-L1 通路表明,免疫细胞中程序性死亡配体 1(PD-L1)的表达也在免疫反应中发挥关键作用。此外,肿瘤微环境(TME)中免疫细胞的分布对于肿瘤发生至关重要。然而,结果仍存在争议,需要进一步研究。在 72 例手术切除的 I-III 期 NSCLC 肿瘤标本的 TME 中评估了 PD-L1 阳性(PD-L1)肿瘤浸润淋巴细胞的分布。与胰岛相比,发现肿瘤基质中 PD-L1 阳性淋巴细胞的分布为主(=0.01)。由于其在基质中的优势,吸烟者中检测到更高的 PD-L1 淋巴细胞浸润。在胰岛和基质中具有较高 CD4 T 细胞浸润、胰岛中 Foxp3CD4 T 细胞浸润和基质中较低 M1 巨噬细胞浸润的肿瘤中,肿瘤基质中 PD-L1 淋巴细胞浸润较高(=0.034,=0.034,=0.005 和=0.034 分别)。同时,在胰岛中具有高水平的 IL-17ACD4 T 细胞和胰岛及基质中 Foxp3CD4 T 细胞的肿瘤中,主要发现胰岛中 PD-L1 淋巴细胞浸润较高(=0.032,=0.009 和=0.034,分别)。PD-L1 淋巴细胞与肿瘤浸润 CD4、Foxp3CD4、IL-17ACD4 T 细胞和 M2 巨噬细胞之间存在显著相关性。肿瘤免疫表型分析显示 PD-L1 表达与 IL17CD4 和 Foxp3CD4 免疫表型之间存在显著相关性。PD-L1 淋巴细胞与 CD4、Foxp3CD4、IL17ACD4 T 细胞、M1 和 M2 巨噬细胞在切除的 NSCLC 的 TME 中的分布相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/d48a72023afc/ijms-25-10827-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/b046f3c43800/ijms-25-10827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/5c6580b8060e/ijms-25-10827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/912d43d7c900/ijms-25-10827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/5c7af4a23385/ijms-25-10827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/d48a72023afc/ijms-25-10827-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/b046f3c43800/ijms-25-10827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/5c6580b8060e/ijms-25-10827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/912d43d7c900/ijms-25-10827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/5c7af4a23385/ijms-25-10827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6438/11477418/d48a72023afc/ijms-25-10827-g005.jpg

相似文献

1
PD-L1 Lymphocytes Are Associated with CD4, Foxp3CD4, IL17CD4 T Cells and Subtypes of Macrophages in Resected Early-Stage Non-Small Cell Lung Cancer.在切除的早期非小细胞肺癌中,PD-L1 淋巴细胞与 CD4、Foxp3CD4、IL17CD4 T 细胞和巨噬细胞亚型相关联。
Int J Mol Sci. 2024 Oct 9;25(19):10827. doi: 10.3390/ijms251910827.
2
PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer.切除的非小细胞肺癌中的 PD-L1 表达和肿瘤微环境模式。
Medicina (Kaunas). 2024 Mar 14;60(3):482. doi: 10.3390/medicina60030482.
3
Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages.肉瘤样肺癌显示出高水平的程序性死亡配体-1(PD-L1)以及TCD3细胞和巨噬细胞的强烈免疫细胞浸润。
Lung Cancer. 2016 Aug;98:51-58. doi: 10.1016/j.lungcan.2016.05.013. Epub 2016 May 21.
4
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.PD-L1 阳性癌相关成纤维细胞在 pN0M0 非小细胞肺癌中的临床意义。
Lung Cancer. 2019 Nov;137:56-63. doi: 10.1016/j.lungcan.2019.09.013. Epub 2019 Sep 16.
5
Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.程序性死亡配体 1 及其周围免疫状态对Ⅰ期肺癌的预后影响。
Clin Lung Cancer. 2020 Jul;21(4):e302-e314. doi: 10.1016/j.cllc.2020.01.013. Epub 2020 Jan 27.
6
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.肿瘤基质中高 CD8 与 FOXP3 的比值和肿瘤细胞中 PTEN 的表达与非转移性三阴性乳腺癌患者的生存改善相关。
BMC Cancer. 2021 Aug 6;21(1):901. doi: 10.1186/s12885-021-08636-4.
7
Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.肿瘤相关巨噬细胞浸润与早期肺腺癌中肿瘤程序性死亡配体 1 的表达有关。
Cancer Sci. 2020 Feb;111(2):727-738. doi: 10.1111/cas.14272. Epub 2020 Jan 6.
8
FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma.可手术切除的非小细胞肺癌中FOXP3浸润淋巴细胞密度及PD-L1表达
Exp Lung Res. 2019 Apr-May;45(3-4):76-83. doi: 10.1080/01902148.2019.1617371. Epub 2019 May 28.
9
PD-L1 expression and infiltration by CD4 and FoxP3 T cells are increased in Xp11 translocation renal cell carcinoma and indicate poor prognosis.Xp11 易位性肾细胞癌中 PD-L1 的表达和 CD4、FoxP3 T 细胞的浸润增加,并提示预后不良。
Histopathology. 2020 Apr;76(5):714-721. doi: 10.1111/his.14047. Epub 2020 Mar 17.
10
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes.免疫微环境在小细胞肺癌中的作用:PD-L1 表达的分布和 FOXP3 阳性肿瘤浸润淋巴细胞的预后作用。
Eur J Cancer. 2018 Sep;101:191-200. doi: 10.1016/j.ejca.2018.06.023. Epub 2018 Aug 1.

引用本文的文献

1
Hirudin inhibits ferroptosis to improve renal fibrosis by targeting the STAT3/NLRP3 signaling pathway.水蛭素通过靶向STAT3/NLRP3信号通路抑制铁死亡以改善肾纤维化。
Acta Cir Bras. 2025 Apr 28;40:e403325. doi: 10.1590/acb403325. eCollection 2025.

本文引用的文献

1
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies.炎症性、排除性或无反应性免疫表型中的肿瘤微环境:机制与策略
Exp Hematol Oncol. 2024 Aug 6;13(1):80. doi: 10.1186/s40164-024-00543-1.
2
PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer.切除的非小细胞肺癌中的 PD-L1 表达和肿瘤微环境模式。
Medicina (Kaunas). 2024 Mar 14;60(3):482. doi: 10.3390/medicina60030482.
3
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.
炎症免疫表型预测免疫检查点抑制剂治疗多种癌症类型的良好临床结局。
J Immunother Cancer. 2024 Feb 14;12(2):e008339. doi: 10.1136/jitc-2023-008339.
4
IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction.白细胞介素-10 通过诱导 PD-L1 抑制抗肿瘤免疫并促进肝转移。
J Hepatol. 2024 Apr;80(4):634-644. doi: 10.1016/j.jhep.2023.12.015. Epub 2023 Dec 30.
5
Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational study.非小细胞肺癌中 PD-L1 表达的真实世界流行率:一项澳大利亚范围内多中心回顾性观察研究。
Pathology. 2023 Dec;55(7):922-928. doi: 10.1016/j.pathol.2023.08.008. Epub 2023 Sep 27.
6
The cancer-immunity cycle: Indication, genotype, and immunotype.癌症免疫周期:指征、基因型和免疫型。
Immunity. 2023 Oct 10;56(10):2188-2205. doi: 10.1016/j.immuni.2023.09.011.
7
Interleukin-17 signaling influences CD8 T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells.白细胞介素-17 信号根据癌细胞中白细胞介素-17 受体亚单位的表达模式影响 CD8 T 细胞免疫和肿瘤进展。
Oncoimmunology. 2023 Oct 5;12(1):2261326. doi: 10.1080/2162402X.2023.2261326. eCollection 2023.
8
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors.联合 PD-L1/TGFβ 阻断允许免疫排斥肿瘤中干细胞样 CD8 T 细胞的扩增和分化。
Nat Commun. 2023 Aug 5;14(1):4703. doi: 10.1038/s41467-023-40398-4.
9
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial.阿特珠单抗辅助化疗用于可切除 II-IIIA 期非小细胞肺癌的总生存期:一项随机、多中心、开放标签、III 期试验(IMpower010)。
Ann Oncol. 2023 Oct;34(10):907-919. doi: 10.1016/j.annonc.2023.07.001. Epub 2023 Jul 17.
10
The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment.Th17 细胞可塑性和功能在肿瘤微环境中的保护和致病作用。
Front Immunol. 2023 Jun 29;14:1192303. doi: 10.3389/fimmu.2023.1192303. eCollection 2023.